- Stocks
- Healthcare
- NYSE: BSX

Price (delayed)

$42.67

Market cap

$60.47B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.08

Enterprise value

$67.88B

Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology,

The equity has grown by 10% YoY

Boston Scientific's debt has decreased by 9% YoY and by 2.1% QoQ

BSX's quick ratio has surged by 112% year-on-year but it is down by 19% since the previous quarter

The EPS has plunged by 103% from the previous quarter and by 102% YoY

Boston Scientific's net income has shrunk by 102% QoQ and by 102% YoY

What are the main financial stats of BSX

Market
Valuations
Earnings

Shares outstanding

1.42B

Market cap

$60.47B

Enterprise value

$67.88B

Price to earnings (P/E)

N/A

Price to book (P/B)

3.99

Price to sales (P/S)

6.1

EV/EBIT

241.56

EV/EBITDA

48.35

EV/Sales

6.85

Revenue

$9.91B

EBIT

$281M

EBITDA

$1.4B

Free cash flow

$1.23B

Per share
Balance sheet
Liquidity

EPS

-$0.08

Free cash flow per share

$0.87

Book value per share

$10.7

Revenue per share

$7

TBVPS

$10.52

Total assets

$30.78B

Total liabilities

$15.45B

Debt

$9.14B

Equity

$15.33B

Working capital

$3.01B

Debt to equity

0.6

Current ratio

1.82

Quick ratio

0.89

Net debt/EBITDA

5.28

Margins
Efficiency
Dividend

EBITDA margin

14.2%

Gross margin

65%

Net margin

-0.8%

Operating margin

-0.8%

Return on assets

-0.4%

Return on equity

-0.8%

Return on invested capital

1.5%

Return on capital employed

1%

Return on sales

2.8%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Boston Scientific stock price performed over time

Intraday

0.23%

1 week

4.3%

1 month

14.58%

1 year

17.23%

YTD

18.69%

QTD

10.4%

How have Boston Scientific's revenue and profit performed over time

Revenue

$9.91B

Gross profit

$6.45B

Operating income

-$79M

Net income

-$82M

Gross margin

65%

Net margin

-0.8%

BSX's operating margin has dropped by 200% since the previous quarter and by 106% year-on-year

Boston Scientific's operating income has plunged by 199% from the previous quarter and by 105% YoY

Boston Scientific's net margin has shrunk by 102% QoQ and by 102% YoY

Boston Scientific's net income has shrunk by 102% QoQ and by 102% YoY

What is Boston Scientific's growth rate over time

What is Boston Scientific stock price valuation

P/E

N/A

P/B

3.99

P/S

6.1

EV/EBIT

241.56

EV/EBITDA

48.35

EV/Sales

6.85

The EPS has plunged by 103% from the previous quarter and by 102% YoY

The stock's price to book (P/B) is 21% more than its last 4 quarters average of 3.3 but 19% less than its 5-year quarterly average of 4.9

The equity has grown by 10% YoY

BSX's P/S is 29% above its 5-year quarterly average of 4.7 and 24% above its last 4 quarters average of 4.9

The revenue has decreased by 8% YoY

How efficient is Boston Scientific business performance

The return on equity has dropped by 103% since the previous quarter and by 102% year-on-year

The return on assets has dropped by 103% since the previous quarter and by 102% year-on-year

BSX's ROIC has plunged by 81% YoY

The ROS has plunged by 74% YoY

What is BSX's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for BSX.

How did Boston Scientific financials performed over time

Boston Scientific's total assets is 99% more than its total liabilities

BSX's quick ratio has surged by 112% year-on-year but it is down by 19% since the previous quarter

BSX's current ratio has surged by 88% year-on-year but it is down by 2.7% since the previous quarter

Boston Scientific's debt is 40% lower than its equity

Boston Scientific's debt to equity has decreased by 17% YoY

The equity has grown by 10% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.